Legacy IMBDS, Inc.: Nasdaq/NYSE listing notice — iMedia Brands receives second Nasdaq non-compliance notice over delayed 10-Q filing

Legacy IMBDS, Inc.

Received second non-compliance notice on June 16, 2023 for failing to file Form 10-Q for period ended April 29, 2023.
Company also has not filed annual Form 10-K for year ended Jan 28, 2023; first notice received May 3, 2023.
Must submit compliance plan by July 3, 2023; if accepted, Nasdaq may grant extension until Oct 25, 2023.
No immediate effect on trading, but indicator will be broadcast over Nasdaq market data.
No assurance that Nasdaq will accept plan or that compliance will be regained within extension period.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Legacy IMBDS, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

June 16, 2023, the Company received a revised notification letter (the “Revised Nasdaq Notice”) from the Listing Qualifications Department of Nasdaq stating that, because the Company has not filed its Quarterly Report on Form 10-Q for the period ended April 29, 2023, and because the Company has not yet filed its Annual Report on Form 10-K for the year ended January 28, 2023, the Company remains not in compliance with Nasdaq Listing Rule 5250(c)(1). The Revised Nasdaq Notice has no immediate effect on the listing or trading of the Company’s securities. In the Revised Nasdaq Notice, Nasdaq reite

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-074238

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.